Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Suven Life Sciences Gains 7%; BSE HEALTHCARE Index Up 0.3%
Mon, 16 Sep 13:35

Suven Life Sciences Gains 7%; BSE HEALTHCARE Index Up 0.3%Image source: peterschreiber.media/www.istockphoto.com

Suven Life Sciences share price has zoomed 7% and is presently trading at Rs 160.9.

Meanwhile, the BSE HEALTHCARE index is at 44,421.3 (up 0.3%).

Among the top gainers in the BSE HEALTHCARE index today are Biocon (up 3.5%) and MAX HEALTHCARE INSTITUTE (up 2.5%).

HIKAL CHEMIC (down 3.0%) and FDC (down 2.7%) are among the top losers today.

Over the last one year, Suven Life Sciences has moved up from Rs 72.6 to Rs 160.9, registering a gain of Rs 88.4 (up 121.8%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,294.8 to 44,421.3, registering a gain of 57.0% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 181.2%), SUVEN PHARMACEUTICALS (up 129.2%) and Glenmark Pharma (up 114.1%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 83,024.9 (up 0.2%).

The top gainers among the BSE Sensex today are JSW Steel (up 2.1%) and NTPC (up 1.9%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 25,398.0 (up 0.2%). JSW Steel and NTPC are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 67,221.1 to 83,024.9, registering a gain of 15,803.8 points (up 23.5%).

Suven Life Sciences Financial Update...

Suven Life Sciences net profit fell 16.4% YoY to Rs -280 million for the quarter ended June 2024, compared to a loss of Rs 241 million a year ago. Net sales declined 73.5% to Rs 10 million during the period as against Rs 38 million in April-June 2023.

For the year ended March 2024, Suven Life Sciences reported 11.2% increase in net profit to Rs -1,051 million compared to net loss of Rs 1,183 million during FY23. Revenue of the company fell 13.6% to Rs 117 million during FY24.

The current Price to earnings ratio of Suven Life Sciences, based on rolling 12 month earnings, stands at -32.2.


Equitymaster requests your view! Post a comment on "Suven Life Sciences Gains 7%; BSE HEALTHCARE Index Up 0.3%". Click here!